Neurosense Therapeutics Ltd(NRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NRSN Neurosense Therapeutics Ltd

未开盘 05-13 16:00:00 EDT

0.8325

-0.0005

-0.06%

盘后0.8325

+0.00000.00%

17:37 EDT

最高0.8350	最低0.8100	成交量10.63万
今开0.8300	昨收0.8330	日振幅3.00%
总市值2,943万	流通市值2,302万	总股本3,535万
成交额8.73万	换手率0.38%	流通股本2,765万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NRSN","market":"US","secType":"STK","nameCN":"Neurosense Therapeutics Ltd","latestPrice":0.8325,"timestamp":1778702400000,"preClose":0.833,"halted":0,"volume":106329,"hourTrading":{"tag":"盘后","latestPrice":0.8325,"preClose":0.8325,"latestTime":"17:37 EDT","volume":2,"amount":1.6982,"timestamp":1778708253605,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0006002400960383493,"floatShares":27646866,"shares":35349800,"eps":-0.436593,"marketStatus":"未开盘","change":-0.0005,"latestTime":"05-13 16:00:00 EDT","open":0.83,"high":0.835,"low":0.81,"amount":87314.78082,"amplitude":0.030012,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.436593,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1778745600000},"marketStatusCode":0,"adr":0,"listingDate":1639026000000,"exchange":"NASDAQ","adjPreClose":0.833,"preHourTrading":{"tag":"盘前","latestPrice":0.83,"preClose":0.833,"latestTime":"08:41 EDT","volume":2124,"amount":1744.9830324,"timestamp":1778676085905,"change":-0.003,"changeRate":-0.003601,"amplitude":0.042137},"postHourTrading":{"tag":"盘后","latestPrice":0.8325,"preClose":0.8325,"latestTime":"17:37 EDT","volume":2,"amount":1.6982,"timestamp":1778708253605,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.74719},"requestUrl":"/m/hq/s/NRSN/tweets","defaultTab":"tweets","newsList":[{"id":"1178074818","title":"《JAMA Neurology》发布Primec治疗ALS的Paradigm IIb期试验结果：展现显著临床疗效与生物学活性","url":"https://stock-news.laohu8.com/highlight/detail?id=1178074818","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178074818?lang=zh_cn&edition=full","pubTime":"2026-03-16 23:34","pubTimestamp":1773675253,"startTime":"0","endTime":"0","summary":"近日，《JAMA Neurology》期刊正式刊登了Primec针对肌萎缩侧索硬化症（ALS）的Paradigm IIb期临床试验数据。该研究由NeuroSense Therapeutics Ltd主导，结果显示Primec在ALS治疗中不仅表现出具有临床意义的疗效指标，还展现出明确的生物学活性证据。\n试验数据证实，Primec在延缓疾病进展、改善患者功能评分等方面产生积极影响，同时通过生物标志物分析验证了其作用于疾病相关通路的能力。这一突破为ALS治疗领域提供了新的方向，也为后续临床开发奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSNW","NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595773919","title":"Neurosense Therapeutics Ltd.盘中异动 早盘快速下挫5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595773919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595773919?lang=zh_cn&edition=full","pubTime":"2025-12-30 23:28","pubTimestamp":1767108514,"startTime":"0","endTime":"0","summary":"北京时间2025年12月30日23时28分，Neurosense Therapeutics Ltd.股票出现异动，股价大幅下跌5.26%。截至发稿，该股报0.720美元/股，成交量5.755万股，换手率0.19%，振幅3.55%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.79%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230232835a6e1e64b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230232835a6e1e64b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4539","NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199570378","title":"Neurosense Therapeutics Ltd - 在加拿大恢复Primec在肌萎缩侧索硬化症中的监管进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1199570378","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199570378?lang=zh_cn&edition=full","pubTime":"2025-12-04 21:41","pubTimestamp":1764855672,"startTime":"0","endTime":"0","summary":"Neurosense Therapeutics Ltd - 在加拿大恢复Primec在肌萎缩侧索硬化症中的监管进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517948396","title":"Neurosense Therapeutics Ltd.盘中异动 急速拉升8.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948396","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948396?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185111,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Neurosense Therapeutics Ltd.股票出现异动，股价大幅上涨8.18%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.08%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223151abe9b0bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223151abe9b0bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516665912","title":"Neurosense Therapeutics Ltd.盘中异动 临近收盘快速下跌5.19%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516665912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516665912?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:00","pubTimestamp":1741035611,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日05时00分，Neurosense Therapeutics Ltd.股票出现波动，股价快速下跌5.19%。截至发稿，该股报1.05美元/股，成交量19.369万股，换手率0.83%，振幅9.03%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.20%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304050011abe69e8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304050011abe69e8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514432004","title":"Neurosense Therapeutics Ltd.盘中异动 快速上涨5.61%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514432004","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514432004?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:30","pubTimestamp":1740753024,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时30分，Neurosense Therapeutics Ltd.股票出现波动，股价快速上涨5.61%。截至发稿，该股报1.13美元/股，成交量1.564万股，换手率0.07%，振幅1.87%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.00%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223024a2580080&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223024a2580080&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514801267","title":"Neurosense Therapeutics Ltd.盘中异动 快速跳水5.60%报1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514801267","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514801267?lang=zh_cn&edition=full","pubTime":"2025-02-26 01:24","pubTimestamp":1740504293,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日01时24分，Neurosense Therapeutics Ltd.股票出现波动，股价大幅下挫5.60%。截至发稿，该股报1.02美元/股，成交量4.1206万股，换手率0.18%，振幅6.45%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.28%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226012453a253ad9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226012453a253ad9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRSN","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512169247","title":"Neurosense Therapeutics Ltd.盘中异动 快速拉升5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512169247","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512169247?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:09","pubTimestamp":1739891370,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时09分，Neurosense Therapeutics Ltd.股票出现波动，股价快速拉升5.63%。截至发稿，该股报1.22美元/股，成交量3.3588万股，换手率0.14%，振幅4.05%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.69%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021823093096279ede&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021823093096279ede&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508514259","title":"Neurosense Therapeutics Ltd.盘中异动 股价大涨6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508514259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508514259?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:48","pubTimestamp":1738594089,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时48分，Neurosense Therapeutics Ltd.股票出现波动，股价急速拉升6.00%。截至发稿，该股报1.18美元/股，成交量4.2066万股，换手率0.18%，振幅3.60%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.30%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224809987971f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224809987971f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRSN","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508994861","title":"Neurosense Therapeutics Ltd.盘中异动 下午盘快速上涨5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508994861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508994861?lang=zh_cn&edition=full","pubTime":"2025-02-01 04:00","pubTimestamp":1738353636,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日04时00分，Neurosense Therapeutics Ltd.股票出现波动，股价大幅上涨5.63%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.69%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020104003696151099&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020104003696151099&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506058583","title":"Neurosense Therapeutics Ltd.盘中异动 下午盘股价大跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506058583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506058583?lang=zh_cn&edition=full","pubTime":"2025-01-28 02:25","pubTimestamp":1738002359,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日02时25分，Neurosense Therapeutics Ltd.股票出现波动，股价急速下挫5.45%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.72%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280225599874d2ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280225599874d2ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505861513","title":"Neurosense Therapeutics Ltd.盘中异动 股价大跌6.19%报1.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505861513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505861513?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:03","pubTimestamp":1737731017,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日23时03分，Neurosense Therapeutics Ltd.股票出现波动，股价快速跳水6.19%。截至发稿，该股报1.06美元/股，成交量3.3792万股，换手率0.15%，振幅3.45%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.55%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124230337a22e6177&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124230337a22e6177&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505706824","title":"Neurosense Therapeutics Ltd.盘中异动 临近收盘急速下挫5.31%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505706824","media":"市场透视","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505706824?lang=zh_cn&edition=full","pubTime":"2025-01-23 04:48","pubTimestamp":1737578921,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日04时48分，Neurosense Therapeutics Ltd.股票出现异动，股价大幅下挫5.31%。截至发稿，该股报1.07美元/股，成交量12.353万股，换手率0.53%，振幅5.31%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.48%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123044841abb4f154&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123044841abb4f154&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504816019","title":"Neurosense Therapeutics Ltd.盘中异动 早盘大幅下跌5.36%报1.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504816019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504816019?lang=zh_cn&edition=full","pubTime":"2025-01-17 23:26","pubTimestamp":1737127593,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日23时26分，Neurosense Therapeutics Ltd.股票出现波动，股价快速下跌5.36%。截至发稿，该股报1.06美元/股，成交量2.521万股，换手率0.11%，振幅3.57%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为1.00%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117232633abaebd57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117232633abaebd57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504593945","title":"Neurosense Therapeutics Ltd.盘中异动 急速拉升5.31%报1.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504593945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504593945?lang=zh_cn&edition=full","pubTime":"2025-01-17 01:54","pubTimestamp":1737050070,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日01时54分，Neurosense Therapeutics Ltd.股票出现波动，股价大幅拉升5.31%。截至发稿，该股报1.09美元/股，成交量6.1213万股，换手率0.26%，振幅6.75%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.17%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501170154309868b495&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501170154309868b495&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501771703","title":"Neurosense Therapeutics Ltd.盘中异动 股价大跌6.42%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501771703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501771703?lang=zh_cn&edition=full","pubTime":"2025-01-08 23:31","pubTimestamp":1736350279,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日23时31分，Neurosense Therapeutics Ltd.股票出现异动，股价大幅下跌6.42%。截至发稿，该股报1.11美元/股，成交量2.0949万股，换手率0.09%，振幅2.95%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.28%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108233119aba359b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108233119aba359b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501552812","title":"Neurosense Therapeutics Ltd.盘中异动 早盘快速拉升5.04%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501552812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501552812?lang=zh_cn&edition=full","pubTime":"2025-01-06 22:31","pubTimestamp":1736173911,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时31分，Neurosense Therapeutics Ltd.股票出现异动，股价急速拉升5.04%。截至发稿，该股报1.25美元/股，成交量1.5929万股，换手率0.07%，振幅0.00%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.27%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223151aba08873&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223151aba08873&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500437521","title":"Neurosense Therapeutics Ltd.盘中异动 股价大涨6.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500437521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500437521?lang=zh_cn&edition=full","pubTime":"2025-01-04 00:15","pubTimestamp":1735920951,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日00时15分，Neurosense Therapeutics Ltd.股票出现异动，股价急速拉升6.96%。截至发稿，该股报1.23美元/股，成交量1.1673万股，换手率0.05%，振幅6.09%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.48%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104001551a2147f01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104001551a2147f01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500661044","title":"Neurosense Therapeutics Ltd.盘中异动 大幅下挫5.24%报1.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500661044","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500661044?lang=zh_cn&edition=full","pubTime":"2025-01-01 01:10","pubTimestamp":1735665004,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日01时10分，Neurosense Therapeutics Ltd.股票出现波动，股价大幅下跌5.24%。截至发稿，该股报1.18美元/股，成交量6.8288万股，换手率0.30%，振幅8.47%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.21%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010101100495f44d31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010101100495f44d31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493765146","title":"Neurosense Therapeutics Ltd.股价重挫19.49% 市值跌493.55万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493765146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493765146?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:35","pubTimestamp":1734964517,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时35分，Neurosense Therapeutics Ltd.股票出现异动，股价大幅下跌19.49%。截至发稿，该股报1.10美元/股，成交量23.3355万股，换手率1.01%，振幅19.04%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.14%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223522a2050bb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223522a2050bb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRSN","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neurosense-tx.com","stockEarnings":[{"period":"1week","weight":-0.0728},{"period":"1month","weight":0.1712},{"period":"3month","weight":-0.1675},{"period":"6month","weight":-0.1528},{"period":"1year","weight":-0.3393},{"period":"ytd","weight":0.0826}],"compareEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":0.0819},{"period":"3month","weight":0.0896},{"period":"6month","weight":0.1047},{"period":"1year","weight":0.2649},{"period":"ytd","weight":0.0886}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NeuroSense Therapeutics Ltd.于2017年2月13日在以色列注册成立。该公司是一家临床阶段的生物技术公司，专注于发现和开发针对神经退行性疾病患者的治疗方法，包括肌萎缩性侧索硬化症（ALS）、阿尔茨海默病（AD）和帕金森病（PD）。公司的主要候选治疗药物PrimeC是一种新型的缓释口服制剂，由两种FDA批准的药物环丙沙星和塞来昔布组成的固定剂量组合。PrimeC旨在通过调节microRNA合成、铁积累和神经炎症来治疗ALS，所有这些都是ALS病理的标志。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.157004},{"month":2,"riseRate":0.6,"avgChangeRate":0.184296},{"month":3,"riseRate":0.4,"avgChangeRate":0.030043},{"month":4,"riseRate":0.6,"avgChangeRate":-0.103871},{"month":5,"riseRate":0.4,"avgChangeRate":-0.0006},{"month":6,"riseRate":0.75,"avgChangeRate":0.40415},{"month":7,"riseRate":0,"avgChangeRate":-0.235872},{"month":8,"riseRate":0.5,"avgChangeRate":-0.118473},{"month":9,"riseRate":0.5,"avgChangeRate":0.06987},{"month":10,"riseRate":0,"avgChangeRate":-0.14429},{"month":11,"riseRate":0.75,"avgChangeRate":0.430569},{"month":12,"riseRate":0.25,"avgChangeRate":-0.202897}],"exchange":"NASDAQ","name":"Neurosense Therapeutics Ltd","nameEN":"Neurosense Therapeutics Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Neurosense Therapeutics Ltd(NRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Neurosense Therapeutics Ltd(NRSN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Neurosense Therapeutics Ltd,NRSN,Neurosense Therapeutics Ltd股票,Neurosense Therapeutics Ltd股票老虎,Neurosense Therapeutics Ltd股票老虎国际,Neurosense Therapeutics Ltd行情,Neurosense Therapeutics Ltd股票行情,Neurosense Therapeutics Ltd股价,Neurosense Therapeutics Ltd股市,Neurosense Therapeutics Ltd股票价格,Neurosense Therapeutics Ltd股票交易,Neurosense Therapeutics Ltd股票购买,Neurosense Therapeutics Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Neurosense Therapeutics Ltd(NRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Neurosense Therapeutics Ltd(NRSN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}